Activation of free fatty acid receptor 1 improves hepatic steatosis through a p38-dependent pathway

Horng Yih Ou, Hung Tsung Wu, Feng Hwa Lu, Yu Chu Su, Hao Chang Hung, Jin Shang Wu, Yi Ching Yang, Chao Liang Wu, Chih Jen Chang

研究成果: Article同行評審

12 引文 斯高帕斯(Scopus)

摘要

Hepatic steatosis is highly correlated with insulin resistance and diabetes. Although, it has been demonstrated that activation of free fatty acid receptor 1 (FFAR1) by agonists showed benefits for the improvement of diabetes, the effects of FFAR1 agonists on hepatic steatosis were unknown. In this study, a high fat diet (HFD)-induced hepatic steatosis animal model was utilized to evaluate the effects of an FFAR1 agonist, GW9508, on hepatic lipid accumulation, and HepG2 hepatoma cells were also used to clarify the possible mechanisms. Administration of GW9508 significantly decreased the hepatic lipid accumulation with decreased expressions of lipogenesis-related proteins in HFD mice. Knockdown of hepatic Ffar1 by lentiviral vectors containing short hairpin RNA targeted to Ffar1 diminished the effect of GW9508 in HFD mice. In addition, GW9508 decreased oleic acid-induced lipid accumulation in HepG2 cells by decreases in the expression of lipogenesis-related proteins. Moreover, GW9508 downregulated the expression of sterol regulatory element-binding protein 1 (SREBP1) through a p38-dependent pathway, whereas knockdown of Ffar1 in HepG2 cells diminished the effect of GW9508 on the decrease in SREBP1. Considering all these results together, GW9508 exerts a therapeutic effect to improve hepatic steatosis through a p38-dependent pathway. Thus, investigation of chemicals that act on FFAR1 might be a new strategy for the treatment of hepatic steatosis.

原文English
頁(從 - 到)165-174
頁數10
期刊Journal of Molecular Endocrinology
53
發行號2
DOIs
出版狀態Published - 2014 7月 9

All Science Journal Classification (ASJC) codes

  • 分子生物學
  • 內分泌

指紋

深入研究「Activation of free fatty acid receptor 1 improves hepatic steatosis through a p38-dependent pathway」主題。共同形成了獨特的指紋。

引用此